baber/WOPTO huggingface dataset:
Patent MX-2017008603-A (MX)
Title: Intermediate film for laminated glass, and laminated glass.
Inventor: KAORU MIKAYAMA
IPC: C03C27/12
Filed: 2016-03-24
Abstract: Provided is an intermediate film for laminated glass, with which it is possible to improve the flexural rigidity, sound insulating properties, and long-term adhesive stability of the laminated glass. This intermediate film for laminated glass has, in at least 80% of the temperature range from 0°C to 30°C, a shear storage equivalent elastic modulus of 10 MPa to 500 MPa, such that the value obtained by dividing the shear storage equivalent elastic modulus at 10°C by the shear storage equivalent elastic modulus at 30°C is 1 to 10, has a glass transition temperature of -25°C to 0°C, and, in the temperature range of -50°C to 0°C, has a maximum tanÎ´ value of 0.1 to 1.
Patent MX-2017008704-A (MX)
Title: Bent glass sheet supported during cooling.
Inventor: HERVÉ THELLIER
IPC: C03B40/00
Filed: 2015-12-29
Abstract: The invention relates to a frame for cooling a bent glass sheet, comprising a support track for the sheet and a removable supporting part which, in the support position and during the blown-air cooling of the sheet, can rest on the upper face of the sheet and along the periphery thereof. The bent sheet being cooled on the cooling frame remains in contact with the frame according to the invention during cooling and its shape more closely matches the desired shape.
Patent MX-2017009578-A (MX)
Title: Processing of lithium containing material including hcl sparge.
Inventor: YATENDRA SHARMA
IPC: C22B3/10
Filed: 2015-10-30
Abstract: A process (10) for the treatment of a lithium containing material (12), the process comprising the steps of: (i) Preparing a process solution from the lithium containing material (12); (ii) Passing the process solution from step (i) to a series of impurity removal steps, one of which is an HCl sparging step 58, thereby providing a substantially purified lithium chloride solution; and (iii) Passing the purified lithium chloride solution of step (ii) to an electrolysis step (70) thereby producing a lithium hydroxide solution. An additional step in which the lithium hydroxide solution produced in step (iii) is carbonated by passing compressed carbon dioxide (88) through the solution, thereby producing a lithium carbonate precipitate, is also disclosed.
Patent MX-2017013501-A (MX)
Title: Bromodomain inhibitor.
Inventor: JEFFREY ALAN STAFFORD
IPC: C07D217/24
Filed: 2016-04-22
Abstract: Described herein is the bromodomain inhibitor 4-[2-(cyclopropylmethoxy)-5-methylsulfonylphenyl]-2-methylisoqu inolin-1-one, including crystalline forms, amorphous forms, solvates, and hydrates thereof, as well as pharmaceutical compositions that include this bromodomain inhibitor. In some embodiments the pharmaceutical composition comprises 4 [2 (cyclopropylmethoxy)-5-methylsulfonylphenyl]-2-methylisoquinoli n-1-one that has been processed by micronization or spray dried dispersion. In some embodiments, the pharmaceutical composition further comprises at least one polymer. In some embodiments, the pharmaceutical compositions comprises a solid polymer matrix comprising 4-[2-(cyclopropylmethoxy)-5-methylsulfonylphenyl]-2-methylisoqu inolin-1-one and at least one polymer. Pharmaceutical compositions comprising 4-[2-(cyclopropylmethoxy)-5-methylsulfonylphenyl]-2-methylisoqu inolin-1-one are useful for the treatment of cancer or neoplastic disease.
Patent MX-2018000994-A (MX)
Title: Dechlorination compositions, compressed solids formed therefrom, and methods of preparing the same.
Inventor: CHRISTOPHER M KAREIS
IPC: C01B17/62
Filed: 2016-07-22
Abstract: A dechlorination composition for dechlorinating water, such as treated water, includes at least one alkali metal sulfite, at least one alkali metal thiosulfate, at least one hydrogenated vegetable oil, and at least one saccharide. The dechlorination composition can also include at least one colorant and at least one halide salt. The dechlorination composition can be formed into a compressed solid. Methods of preparing compressed solids of dechlorination compositions are also disclosed.
Patent MX-2018002386-A (MX)
Title: Surgical staples comprising features for improved fastening of tissue.
Inventor: SHELTON FREDERICK E IV
IPC: A61B17/064
Filed: 2016-08-10
Abstract: A surgical staple cartridge is disclosed comprising a plurality of staples removably stored within the surgical staple cartridge. The staples comprise staple legs which extend from a staple base portion. The staple legs comprise staple tips configured to pierce tissue and contact a corresponding forming pocket of an anvil of surgical stapling instrument.
Patent MX-2018003411-A (MX)
Title: Glycotargeting therapeutics.
Inventor: JEFFREY A HUBBELL
IPC: A61K39/00
Filed: 2016-09-16
Abstract: Several embodiments of the present disclosure relate to therapeutic compositions configured to target the liver of a subject and that are useful in the treatment or prevention of one or more of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. In several embodiments, the compositions are configured for clearance of a circulating protein or peptide or antibody associated with one or more of the above-mentioned maladies. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
Patent MX-2018006919-A (MX)
Title: Inverse emulsion compositions.
Inventor: HONG YANG
IPC: C08F20/56
Filed: 2016-12-07
Abstract: An inverse emulsion composition comprising: one or more hydrophobic liquids having a boiling point at least about 100 °C; up to about 38% by weight of one or more acrylamide-(co)polymers; one or more emulsifier surfactants; and one or more inverting surfactants; wherein, when the composition is inverted in an aqueous solution, it provides an inverted solution having a filter ratio using a 1.2 micron filter (FR 1.2) of about 1.5 or less.
Patent MX-2018007068-A (MX)
Title: A tin-containing zeolitic material having a bea framework structure.
Inventor: RALF PELZER
IPC: C01B39/12
Filed: 2016-12-07
Abstract: An incipient wetness impregnation method for preparing a tin-containing zeolitic material having framework type BEA, a novel tin-containing zeolitic material having framework type BEA and its use.
Patent MX-2018008991-A (MX)
Title: Terminal for a bingo game.
Inventor: BERNARDINO HERNÁNDEZ JIMÉNEZ
IPC: A63F3/06
Filed: 2017-01-27
Abstract: The invention relates to a terminal (1) for a bingo game, which comprises: at least one control and communications module (2) for executing a local algorithm for representing the game on at least one screen (3), and which is provided with at least one connection (4) for communicating with various external programs that manage the bingo game; at least one interface (5) for interacting with at least one player; and at least one payment means manager (6) for inputting and recording the payments per game by the players and enabling the game in the terminal (1). The terminal comprises at least one printing server (7) with means for printing physical cards (8) for the game, and which is associated with the control and communications module (2).
Patent MX-2018009613-A (MX)
Title: Container assembly having a cell assembly therein and methods for forming.
Inventor: CALVIN JAY KORTMAN
IPC: B65D5/36
Filed: 2017-02-09
Abstract: A collapsible container assembly includes a folding container having at least two walls pivotable relative to each other at a corresponding corner disposed between the at least two walls, the folding container movable between a collapsed position wherein the at least two walls are disposed adjacent to one another and an extended position where in the at least two walls are spaced from each other, and an inside cellular structure (114) attached to at least a portion of the at least two walls, the cellular structure (114) comprising a plurality of panels (132) forming the cellular structure (114).
Patent MX-2018010452-A (MX)
Title: Mixer, system for applying a building material and method for producing a structure from building material.
Inventor: PATRICK KUHN
IPC: B01F7/04
Filed: 2017-03-01
Abstract: A mixer (1) has a drum (2) with at least one inlet (6) and one outlet (7). The mixer (1) further has a drive (3) and a stirring shaft (4), which is arranged in the drum (2) and coupled to the drive (3). The mixer (1) further has a conveyor device (5) which is arranged in the drum (2), on the same axis as the stirring shaft (4).
Patent MX-2018012434-A (MX)
Title: NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS.
Inventor: NICOLAS POIRIER
IPC: C07K16/28
Filed: 2017-04-14
Abstract: The present invention provides new anti-SIRPa antibodies able to specifically antagonize the interaction between SIRPa and CD47, without affecting the interaction between SIRPg and CD47, and their uses.
Patent MX-2018012446-A (MX)
Title: Fail-safe led system.
Inventor: HUI ZHANG
IPC: H05B37/03
Filed: 2017-04-10
Abstract: The present disclosure relates to a fail-safe LED system including an LED circuit arrangement. The LED circuit arrangement includes a plurality of LED strings arranged in parallel with respect to each other. The LED circuit arrangement is supplied with electrical current from a constant current power supply. The fail-safe LED system includes structure for detecting a in at least one of the LED strings a failure that causes increased current to pass through remaining operational LED strings of the plurality of LED strings. The fail-safe LED system also includes a current correction string arranged in parallel with respect to the plurality of LED strings. When activated in response to the detection of a failure, the current correction string accommodates current from the constant current power supply such that the current passing through each operational LED string is reduced to a corrected current level.
Patent MX-2018012624-A (MX)
Title: Power factor correction circuits and methods including partial power factor correction operation for boost and buck power converters.
Inventor: CHARLES E GREEN
IPC: H02M1/42
Filed: 2017-04-14
Abstract: A drive includes an inverter power circuit that applies power to an electric motor of a compressor from a direct current (DC) voltage bus. A power factor correction (PFC) circuit outputs power to the DC voltage bus based on input alternating current (AC) power. The PFC circuit includes: (i) a switch having a first terminal, a second terminal, and a control terminal; (ii) a driver that switches the switch between open and closed states based on a control signal; (iii) an inductor that charges and discharges based on switching of the switch; and (iv) a circuit that outputs a signal indicating whether the switch is in the open state or the closed state based on a voltage across the first and second terminals of the switch.
Patent MX-2019000570-A (MX)
Title: Homeopathic composition based on venom of the scorpion rhopalurus junceus and use in aquaculture.
Inventor: MAZÓN SUÁSTEGUI JOSE MANUEL
IPC: A01K61/59
Filed: 2018-12-19
Abstract: The present invention relates to homeopathic compositions based on venom of the scorpion Rophalurus junceus for use in aquaculture as an immunostimulant. The present invention also comprises the novel use of peptides of venom of the scorpion Rophalurus junceus, in a biologically acceptable amount, as an immunomodulator in the culture of marine organisms, fish, crustaceans and/or bivalves.
Patent MX-2019003618-A (MX)
Title: Pyrimidinyl tyrosine kinase inhibitors.
Inventor: PATRICK CONLON
IPC: A61P37/00
Filed: 2014-12-08
Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
Patent MX-2019004946-A (MX)
Title: Reelable pipe.
Inventor: GEIR ENDAL
IPC: F16L11/20
Filed: 2017-10-12
Abstract: A reelable pipeline comprising a pipe-in-pipe section and a single pipe section coupled to the pipe-in-pipe section. The single pipe section has a bending stiffness that is different from the bending stiffness of the pipe-in-pipe section, the reelable pipeline further comprising a transition piece connected between the pipe-in-pipe section and the single pipe section and having a bending stiffness that varies along its length.
Patent MX-2019005415-A (MX)
Title: Antibodies to il-6 and use thereof.
Inventor: JOHN LATHAM
IPC: C07K16/24
Filed: 2011-05-20
Abstract: Disclosed are therapeutic methods using IL-6 antagonists such as an Ab 1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof Patients will preferably comprise those exhibiting (or at Ïsk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.
Patent MX-2019006013-A (MX)
Title: A pharmaceutical composition for averting opioid addiction.
Inventor: JOHN DAVIS
IPC: C07K16/22
Filed: 2017-11-28
Abstract: A pharmaceutical composition for averting opioid addiction in a patient is disclosed. The composition can be used in a patient suffering from moderate to severe low back pain (LBP). The composition is useful in a patient diagnosed with low back pain, and comprises a therapeutically effective amount of an antibody that binds specifically to nerve growth factor (NGF) or an antigen binding fragment thereof; and is used in the absence of an opioid to relieve pain, and avert opioid addiction in a patient.
Patent MX-2019006519-A (MX)
Title: Methods and systems for purifying non-complexed botulinum neurotoxin.
Inventor: Curtis L Ruegg
IPC: C12N1/08
Filed: 2012-04-20
Abstract: Methods and systems for chromatographically purifying a botulinum neurotoxin are provided. These methods and systems allow for efficient purification of a non-complexed form of the botulinum neurotoxin in high purity and yield that can be used as an active ingredient in pharmaceutical preparations.
Patent MX-2019013974-A (MX)
Title: Complexes of viral-based therapeutic agents and modified poly(beta-amino ester)s.
Inventor: BORROS GOMEZ SALVADOR
IPC: A61K47/59
Filed: 2018-05-22
Abstract: Disclosed are complexes of virus-based therapeutic agents with polymers that are poly(beta-amino ester)s (PBAEs) modified with at least one oligopeptide. Also disclosed are methods of treatment using these complexes and methods of encapsulating said complexes to form nanoparticles.
Patent MX-2020008369-A (MX)
Title: Control method for internal combustion engine and control device for internal combustion engine.
Inventor: HAMANE SHOUTA
IPC: F02N11/08
Filed: 2018-02-15
Abstract: If an internal combustion engine 1 that has been automatically stopped is to be restarted during a decrease in engine speed, a control unit 8 starts cranking when the crank angle of a cylinder of the internal combustion engine 1 in the compression stroke is closer to bottom dead center than a threshold value set in advance. More specifically, if the engine speed of the internal combustion engine 1 is forward rotation, cranking is begun when the crank angle of the cylinder of the internal combustion engine 1 in the compression stroke is closer to bottom dead center than a threshold value A set in advance. Moreover, if the engine speed of the internal combustion engine 1 is backward rotation, cranking is begun when the crank angle of the cylinder of the internal combustion engine 1 in the compression stroke is closer to bottom dead center than a threshold value B set in advance.
Patent MX-2020009791-A (MX)
Title: Multifocal plane based method to produce stereoscopic viewpoints in a dibr system (mfp-dibr).
Inventor: VALLI SEPPO T
IPC: H04N13/344
Filed: 2019-03-20
Abstract: Some embodiments of an example method may include receiving an input image with depth information; mapping the input image to a set of focal plane images; orienting the set of focal plane images using head orientation information to provide stereo disparity between left and right eyes; and displaying the oriented set of focal plane images. Some embodiments of another example method may include: receiving a description of three-dimensional (3D) content; receiving, from a tracker, information indicating motion of a viewer relative to a real-world environment; responsive to receiving the information indicating motion of the viewer, synthesizing motion parallax by altering multi-focal planes of the 3D content; and rendering an image to the multi-focal plane display using the altered multi-focal plane rendering.
Patent MX-2020010084-A (MX)
Title: Anticancer pharmaceutical compositions for combined therapy.
Inventor: BINASCHI MONICA
IPC: A61P35/00
Filed: 2019-03-28
Abstract: The present invention relates to new combinations of antitumour or anticancer agents for the tumour combination therapy, pharmaceutical compositions intended for combined use and kit containing compositions of different antitumour agents for combined use. In particular the present invention relates to combinations of various tumour agents with the PBK-Class I inhibitor 5-(7-methanesulfonyl-2-morpholin-4-yl- 6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-il-ami ne or pharmaceutically acceptable salts thereof.
Patent MX-2020011739-A (MX)
Title: Cleansing composition.
Inventor: RILEY ROBERT GEORGE
IPC: A61K8/46
Filed: 2019-05-08
Abstract: A sulphate free cleansing composition for hair, scalp or skin comprising, in an aqueous continuous phase: a total amount of anionic surfactant, amphoteric surfactant and zwitterionic surfactant consisting of: (i) from 3 wt % to 13 wt %, by weight of the total composition at 100 % activity, of an alpha olefin sulfonate anionic surfactant of general formula (I): R<sup>1</sup>-CH=CH-CH<sub>2</sub>-SO<sub>3</sub>-M+ (I) in which R1 is selected from linear or branched alkyl groups having from 11 to 13 carbon atoms and mixtures thereof; and M is a solubilizing cation; (ii) from 1 to 6%, by weight of an amphoteric or zwitterionic surfactant, selected from an alkyl betaine of general formula (II) R<sup>2</sup>-N+(CH<sub>3</sub>)<sub>2</sub>-CH<sub>2</sub>-COO- M+ (II) wherein R<sup>2</sup> = C12 (Lauryl) or Coco derived; an alkyl hydroxy sultaine of general formula (III), R<sup>3</sup>-N+(CH<sub>3</sub>)<sub>2</sub>-CH<sub>2</sub>-CH( 0H)-CH<sub>2</sub>-S0<sub>3</sub>- M+ (III) wherein R<sup>3</sup> = C12 (Lauryl) or Coco derived; an alkyl aminopropyl hydroxy sultaine of general formula (IV), R<sup>4</sup>-C0-NH-(CH<sub>2</sub>)<sub>3</sub>-N+(CH<sub>3</s ub>)<sub>2</sub>-CH<sub>2</sub>-CH(0H)-CH<sub>2</sub>-S0<sub>3</ sub>- M+ (IV) wherein R<sup>4</sup> = C12 (Lauryl) or Coco derived; an alkyl amphoacetate of general formula (V), R5-C0-NH-(CH2)2-N(CH2-CH2-0H)(CH2-C00- M+) (V) wherein R<sup>5</sup> = C12 (Lauryl) or Coco derived; and mixtures thereof; (iii) from 0.05 wt % to 0.5 wt % of a cationic polymer; (iv) an inorganic electrolyte; and (iv) water; in which the weight ratio of (i) to (ii) ranges from 1 :1 to 6:1 and the pH of the composition is from 3 to 6.5.
Patent MX-2020012060-A (MX)
Title: Method for delivery of biologic agents from a topical formulation.
Inventor: STEWARD LANCE
IPC: A61K8/00
Filed: 2019-05-10
Abstract: Methods for delivery of a biologic agent to the dermis or superficial muscles by topical application of the agent are provided. The methods comprise, in one embodiment, treating or conditioning a skin area to disrupt the stratum corneum in the skin area to define a treated skin area and applying a formulation comprising a biologic agent to the treated skin area.
Patent MX-2020013768-A (MX)
Title: Disubstituted 5(3)-pyrazole carboxylates and a process for their preparation from enolates and fluoroalkylaminoreagents (far) reagents.
Inventor: NEEFF ARND
IPC: C07C315/04
Filed: 2019-06-14
Abstract: The present invention relates to disubstituted 5(3)-pyrazole carboxylates of the formula (la) or (lb) and a process for their preparation wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> and n are defined as above.
Patent MX-2021000748-A (MX)
Title: Delivery devices for administering drugs.
Inventor: CHAN JAMES
IPC: A61M5/31
Filed: 2019-07-23
Abstract: Delivery devices for administering drugs are disclosed. An example apparatus, includes a body including: a handle in which a syringe assembly is to be disposed; a base having a bottom face to be disposed adjacent a user; and an absorbent material attached to the bottom face, the absorbent material structured to hold a fluid to be released onto the user prior to or during an injection procedure.
Patent MX-2021002624-A (MX)
Title: Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements.
Inventor: WASSERMAN YORAM
IPC: A61N1/04
Filed: 2019-11-18
Abstract: Tumor treating fields (TTFields) can be delivered to a subject's body at higher field strengths by switching off one or more electrode elements that are overheating without switching off other electrode elements that are not overheating. This may be accomplished using a plurality of temperature sensors, with each of the temperature sensors positioned to sense the temperature at a respective electrode element; and a plurality of electrically controlled switches, each of which is wired to switch the current to an individual electrode element on or off. A controller input signals from the temperature sensors to determine the temperature at each of the electrode elements, and controls the state of the control input of each of the electrically controlled switches to selectively switch off the current or adjusted the duty cycle at any electrode element that is overheating.
Patent MX-2021005383-A (MX)
Title: Phytopharmacological composition of hydroalcoholic extract of sechium edule as healing.
Inventor: FRAGOSO GONZÁLEZ GLADIS DEL CARMEN
IPC: A61K36/42
Filed: 2021-04-29
Abstract: The present invention relates to the topical application of the rSe-HA extract-controlled edema and regulated cell transit in the TPA-induced atrial inflammation model and accelerated wound closure in the excision wound model in healthy mice and obese mice with resistance to TPA insulin.
Patent MX-2021010228-A (MX)
Title: Administration of pd-1 inhibitors for treating skin cancer.
Inventor: LOWY ISRAEL
IPC: A61P35/00
Filed: 2020-02-27
Abstract: The disclosure relates to methods for treating or inhibiting the growth of a tumor in a patient with a skin cancer, wherein the methods include administering to the patient a therapeutically effective amount of a programmed death 1 (PD-1 ) inhibitor (e.g., an antibody or antigen-binding fragment thereof that specifically binds PD-1, PD-L1, and/or PD-L2). In certain embodiments, the method includes administering to the patient a therapeutically effective amount of a PD-1 inhibitor as adjuvant treatment after the patient has completed surgery and optionally radiation therapy for skin cancer, such as CSCC, and is at high risk for disease recurrence. In certain embodiments, the method includes administering to the skin cancer patient a therapeutically effective amount of a PD-1 inhibitor as neoadjuvant treatment before planned surgery for skin cancer. In certain embodiments, the method includes administering to skin cancer patient a therapeutically effective amount of a PD-1 inhibitor as neoadjuvant treatment before planned surgery for skin cancer and subsequently administering to the patient a PD-1 inhibitor as adjuvant therapy after such surgery.